Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered into its first Exclusive Channel Collaboration (ECC) with a startup backed by an investment fund sponsored by Harvest Capital Strategies, LLC. The fund is believed to be the world’s first fund dedicated to the inventions and discoveries of a single company. The collaboration with the startup entity, Thrive Agrobiotics, Inc., will seek to utilize Intrexon’s ActoBiotics® platform to express nutritive proteins for improving the overall growth and feed efficiency in piglets, thereby expanding the application of this innovative biologic delivery platform to animals.
{iframe}http://investors.dna.com/2015-10-01-Intrexon-Establishes-First-Collaboration-with-Dedicated-Fund?utm_source=BioHealth+Tech+News+and+Events+-10/8&utm_campaign=10-8-15&utm_medium=email{/iframe}